Share the post "Suven Life Sciences Ltd.’s Quarterly Result and Earnings Report for Q4(Mar 2024) : Sales decreased by 8.66 % in YoY and decreased by 2.69 % in QoQ"
Highlights
- Sales over the Year and quarter: The company’s sales declined by -8.66 % over the year, decrease in net sales/revenue by -2.69 %.
- Income over the Year and quarter: There has been decline in other income over the past year which is -23.57 %, Marginal decrease of -29.37% in other income during this quarter.
- Profit over the Year and quarter: Challenges in sustaining profitability for Suven Life Sciences Ltd.. Profit dropped by -3.99 % Year to Year, Suven Life Sciences Ltd.’s profitability dropped by -36.45 % Quarter to Quarter.
- EPS over the Year and quarter: EPS increased by 4.27 % Year to Year. EPS decreased by -36.46 % in previous quarter. Analysis needed for shareholder value.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 2.611 Cr | Rs. 2.451 Cr | Rs. 2.385 Cr | -2.69 % | -8.66 % |
| Expenses | Rs. 34.14 Cr | Rs. 48.64 Cr | Rs. 32.67 Cr | -32.83 % | -4.31 % |
| Operating Profit | Rs. -31.53 Cr | Rs. -46.19 Cr | Rs. -30.29 Cr | + 34.42 % | + 3.93 % |
| OPM % | -1207.58 % | -1884.54 % | -1270.02 % | + 614.52 % | -62.44 % |
| Other Income | Rs. 5.6 Cr | Rs. 6.06 Cr | Rs. 4.28 Cr | -29.37 % | -23.57 % |
| Interest | Rs. 0.05 Cr | Rs. 0.04 Cr | Rs. 0.03 Cr | -25 % | -40 % |
| Depreciation | Rs. 1.67 Cr | Rs. 1.6 Cr | Rs. 1.51 Cr | -5.63 % | -9.58 % |
| Profit before tax | Rs. -27.65 Cr | Rs. -41.77 Cr | Rs. -27.55 Cr | + 34.04 % | + 0.36 % |
| Tax % | -0 % | -0 % | -3.64 % | -3.64 % | -3.64 % |
| Net Profit | Rs. -27.65 Cr | Rs. -41.77 Cr | Rs. -26.54 Cr | + 36.46 % | + 4.01 % |
| EPS in Rs | Rs. -1.17 | Rs. -1.92 | Rs. -1.22 | + 36.46 % | -4.27 % |
Today, we’re looking at Suven Life Sciences Ltd.’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a significant year-over-year sales decline of -8.66 %. However, it did see a marginal slip of -2.69 % from the previous quarter. Expenses decreased slightly by -32.83 % quarter-on-quarter, aligning with the annual decline of -4.31 %. Operating profit, while up 3.93 % compared to last year, faced a quarter-on-quarter increase of 34.42 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -62.44 %, but an expansion of 614.52 % sequentially. Other income fell by -29.37 % compared to the last quarter, despite an annual decline of -23.57 %. Interest expenses dropped significantly by -25 % from the previous quarter, yet the year-over-year decrease remains at a moderate -40 %. Depreciation costs fell by -5.63 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -9.58 %. Profit before tax grew annually by 0.36 % but saw an increase from the preceding quarter by 34.04 %.
Tax expenses as a percentage of profits decreased slightly by -3.64 % compared to last year, with a more notable quarter-on-quarter decrease of -3.64 %. Net profit rose by 4.01 % year-on-year but experienced a 36.46 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -4.27 % but a quarterly rise of 36.46 %. In summary, Suven Life Sciences Ltd.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 2.611 Cr | Rs. 2.451 Cr | Rs. 2.385 Cr | -2.69 % | -8.66 % |
| Expenses | Rs. 34.14 Cr | Rs. 48.64 Cr | Rs. 32.67 Cr | -32.83 % | -4.31 % |
| Operating Profit | Rs. -31.53 Cr | Rs. -46.19 Cr | Rs. -30.29 Cr | + 34.42 % | + 3.93 % |
| Net Profit | Rs. -27.65 Cr | Rs. -41.77 Cr | Rs. -26.54 Cr | + 36.46 % | + 4.01 % |
| EPS in Rs | Rs. -1.17 | Rs. -1.92 | Rs. -1.22 | + 36.46 % | -4.27 % |
In reviewing Suven Life Sciences Ltd.’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales experienced a decrease of -8.66 % year-on-year, although there was a slight dip of -2.69 % from the previous quarter. Expenses decreased by -4.31 % compared to the previous year, with a decrease of -32.83 % quarter-on-quarter. Operating Profit surged by 3.93 % annually, and saw a 34.42 % increase from the last quarter.
Net Profit showed yearly increase of 4.01 %, and experienced a 36.46 % increase from the previous quarter. Earnings Per Share (EPS) fell by -4.27 % annually, however rose by 36.46 % compared to the last quarter. In essence, while Suven Life Sciences Ltd. exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
